We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $72.6B
1-Year Est. Return 54.88%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+30.27%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$116B
AUM Growth
+$12.9B
Cap. Flow
-$8.24B
Cap. Flow %
-7.11%
Top 10 Hldgs %
14.35%
Holding
3,987
New
584
Increased
1,418
Reduced
1,365
Closed
596
Avg Time Held
10.7 quarters
Top 10 Avg Time Held
3.9 quarters
Top 20 Avg Time Held
6 quarters

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$806M
2
ABBV icon
AbbVie
ABBV
+$481M
3
TMUS icon
T-Mobile US
TMUS
+$464M
4
KR icon
Kroger
KR
+$430M
5
BIDU icon
Baidu
BIDU
+$423M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.35B
2
AGN
Allergan plc
AGN
+$1.26B
3
S
Sprint Corporation
S
+$675M
4
AMGN icon
Amgen
AMGN
+$488M
5
HUM icon
Humana
HUM
+$450M

Sector Composition

Rank Sector Weight
1 Healthcare 23.76%
2 Technology 16.41%
3 Consumer Staples 10.58%
4 Consumer Discretionary 10.12%
5 Communication Services 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SLS icon
3351
SELLAS Life Sciences
SLS
$2.34B
$42K ﹤0.01%
+14,360
New +$39K
2020 Q2
0 quarters
SNES icon
3352
SenesTech
SNES
$3.8M
$42K ﹤0.01%
9
-19
-68% -$102K
2019 Q4
2 quarters
MOHO
3353
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$42K ﹤0.01%
+14,900
New +$58.5K
2020 Q2
0 quarters
KGJI
3354
DELISTED
Kingold Jewelry Inc.
KGJI
$42K ﹤0.01%
+58,544
New +$62.4K
2020 Q2
0 quarters
CLSK icon
3355
CleanSpark
CLSK
$2.71B
$38K ﹤0.01%
+14,600
New +$27.6K
2020 Q2
0 quarters
TAOP icon
3356
Taoping
TAOP
$3.98M
$38K ﹤0.01%
+45
New +$33K
2020 Q2
0 quarters
IMH
3357
DELISTED
Impac Mortgage Holdings Inc.
IMH
$38K ﹤0.01%
22,768
+7,968
+54% +$14.7K
2019 Q3
3 quarters
NES
3358
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$38K ﹤0.01%
16,500
+1,600
+11% +$2.69K
2019 Q2
4 quarters
WSG
3359
DELISTED
Wanda Sports Group Company Limited American Depositary Shares
WSG
$37K ﹤0.01%
17,600
+7,500
+74% +$17.9K
2020 Q1
1 quarter
SRTS icon
3360
Sensus Healthcare
SRTS
$49.4M
$34K ﹤0.01%
+11,234
New +$29.3K
2020 Q2
0 quarters
AIRTW
3361
DELISTED
Air T Inc Warrants
AIRTW
$31K ﹤0.01%
419,936
-119,500
-22% -$10.4K
2019 Q2
4 quarters
PWCM
3362
PowerCompute Inc
PWCM
$1.69M
$30K ﹤0.01%
+29
New +$19.7K
2020 Q2
0 quarters
SGLY icon
3363
Singularity Future Technology
SGLY
$3.66M
$30K ﹤0.01%
+71
New +$21.8K
2020 Q2
0 quarters
MDRR
3364
Medalist Diversified Inc
MDRR
$17.1M
$29K ﹤0.01%
+983
New +$28.6K
2020 Q2
0 quarters
AENZ
3365
DELISTED
Aenza S.A.A.
AENZ
$29K ﹤0.01%
+4,451
New +$25.8K
2020 Q2
0 quarters
TMDI
3366
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$29K ﹤0.01%
34,645
-258,655
-88% -$132K
2019 Q4
2 quarters
LGMK
3367
DELISTED
LogicMark
LGMK
$25K ﹤0.01%
+10
New +$21.3K
2020 Q2
0 quarters
SCON
3368
DELISTED
Superconductor Technologies Inc.
SCON
$25K ﹤0.01%
+6,600
New +$21.2K
2020 Q2
0 quarters
BGI
3369
DELISTED
Birks Group
BGI
$24K ﹤0.01%
+30,400
New +$18.2K
2020 Q2
0 quarters
AAU
3370
DELISTED
Almaden Minerals Ltd
AAU
$23K ﹤0.01%
+47,399
New +$20.4K
2020 Q2
0 quarters
KIQ
3371
DELISTED
Kelso Technologies Inc.
KIQ
$23K ﹤0.01%
35,475
+17,030
+92% +$9.57K
2019 Q3
3 quarters
PTE
3372
DELISTED
PolarityTE, Inc. Common Stock
PTE
$22K ﹤0.01%
700
-86
-11% -$2.29K
2019 Q4
2 quarters
CHAP
3373
DELISTED
Chaparral Energy, Inc.
CHAP
$21K ﹤0.01%
+31,801
New +$16.7K
2020 Q2
0 quarters
NDRA icon
3374
ENDRA Life Sciences
NDRA
$8.86M
$18K ﹤0.01%
+1
New +$29K
2020 Q2
0 quarters
NSPR icon
3375
InspireMD
NSPR
$24.1M
$18K ﹤0.01%
+2,540
New +$25.8K
2020 Q2
0 quarters

Similar funds

Renaissance Technologies's Q2 2020 Portfolio in Review

As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.

  • Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
  • Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
  • Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
  • Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
  • Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
  • Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
  • Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.

Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.